SMOFLIPID

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug SMOFLIPID contains a combination of these active pharmaceutical ingredients (APIs):

1	Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL
	Read more about Soybean oil, refined
2	Triglycerides, medium chain UNII C9H2L21V7U - MEDIUM-CHAIN TRIGLYCERIDES
	Read more about Triglycerides, medium chain
3	Olive oil, refined UNII 6UYK2W1W1E - OLIVE OIL
	Read more about Olive oil, refined
4	Fish oil (Omega-3 polyunsaturated fatty acids) UNII XGF7L72M0F - FISH OIL
	Read more about Omega-3-acid ethyl esters

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509505301151318, 509505303154314
CA	Health Products and Food Branch	02396963
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	30256-06-12
EE	Ravimiamet	1164709, 1164710, 1164721, 1164732, 1164743, 1164754, 1379167, 1790265, 1798038, 1798049
ES	Centro de información online de medicamentos de la AEMPS	66581
FR	Base de données publique des médicaments	60650173
GB	Medicines & Healthcare Products Regulatory Agency	114659, 215158, 387559
HK	Department of Health Drug Office	53582
HR	Agencija za lijekove i medicinske proizvode	HR-H-039535852
IL	מִשְׂרַד הַבְּרִיאוּת	6976, 7109
LT	Valstybinė vaistų kontrolės tarnyba	1017699, 1017700, 1017701, 1017702, 1017703, 1017704, 1022138, 1022139, 1022140, 1022141, 1022142, 1022143, 1085784, 1086928, 1086929
MT	Medicines Authority	AA565/40001, AA565/40002
NZ	Medicines and Medical Devices Safety Authority	14430
PL	Rejestru Produktów Leczniczych	100134861
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W42573001, W42573002, W42573003
SG	Health Sciences Authority	13246P
US	FDA, National Drug Code	63323-820